Total Funding
3
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
408634
SpinChip is considered the ultimate concept for in vitro diagnosis analyses in a point of care setting.
- Rolf Jahren: VP Instrument Development and Industrialisation
- Stig Morten Borch: Chief Scientific Officer & Co-Founder
About the Company
SpinChip Diagnostics will market the new state of the art platform for in vitro diagnostics point of care analyses. The technology will provide significant value by enabling faster, easier and more reliable point of care analyses at hospitals and in decentralized medical settings. The fully automated device analyses blood samples within a few
minutes.
The company will initially focus on the rapid cardiac segment. A Troponin-I analysis is under development and the portfolio will swiftly be broaden to a cardiac panel. The SpinChip platform will deliver the same quality as the very best high-sensitivity central laboratory analyzers, thus making the customer value proposition significantly more attractive than competing point of care platforms.
